Phase I evaluation of the safety and pharmacokinetics of a single-dose intravenous injection of a murine monoclonal antibody against Hantaan virus in healthy volunteers.

Xu, Rong

Phase I evaluation of the safety and pharmacokinetics of a single-dose intravenous injection of a murine monoclonal antibody against Hantaan virus in healthy volunteers. [electronic resource] - Antimicrobial agents and chemotherapy Dec 2009 - 5055-9 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial

1098-6596

10.1128/AAC.00728-09 doi


Animals
Antibodies, Monoclonal--administration & dosage
Antiviral Agents--administration & dosage
Area Under Curve
Enzyme-Linked Immunosorbent Assay
Female
Half-Life
Hantaan virus--immunology
Humans
Injections, Intravenous
Male
Mice
Young Adult